https://www.selleckchem.com/pr....oducts/kenpaullone.h
-TIPS HE and is a choice for evaluating the prognosis of patients undergoing TIPS. Histological changes after direct-acting antivirals (DAAs) therapy in hepatitis C virus (HCV) patients has not been elucidated. Whether the predominantly progressive, indeterminate and predominately regressive (P-I-R) score, evaluating fibrosis activity in hepatitis B virus patients has predictive value in HCV patients has not been investigated. To identify histological changes after DAAs therapy and to evaluate the predictive value of the P-I-R score
Like
Comment
Share
